Inflammatory Myopathies: Utility of Antibody Testing.
Antisynthetase syndrome
Dermatomyositis
Inflammatory myopathies
Overlap myositis
Sporadic inclusion body myositis
Journal
Neurologic clinics
ISSN: 1557-9875
Titre abrégé: Neurol Clin
Pays: United States
ID NLM: 8219232
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
entrez:
25
7
2020
pubmed:
25
7
2020
medline:
18
11
2020
Statut:
ppublish
Résumé
Inflammatory myopathies are a group of immune-mediated muscle disorders comprising dermatomyositis; polymyositis; overlap myositis, including antisynthetase syndromes and nonspecific myositis, immune-mediated necrotizing myopathies, and sporadic inclusion body myositis. They are now much more eloquently classified both pathologically and clinically because of the discovery of several myositis-specific and myositis-associated antibodies. These antibodies also aid in choosing the best treatment options in each case. Based on the initial classifications of inflammatory myopathies, inclusion body myositis, overlap myositis, and necrotizing myositis were all included in the polymyositis group. This article discusses cases, diagnostic tools, associated antibodies, and pathology.
Identifiants
pubmed: 32703475
pii: S0733-8619(20)30039-6
doi: 10.1016/j.ncl.2020.05.001
pii:
doi:
Substances chimiques
Autoantibodies
0
Methylprednisolone
X4W7ZR7023
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
661-678Informations de copyright
Published by Elsevier Inc.